|
Lecture hall 2
|
Scientific working group session III (Chairs: Bert Klebl/Richard Schäfer) |
|
| 09:00 - 09:20 |
T15 - Stem cell based assays as the next generation phenotypic drug screens?
Bert Klebl, Lead Discovery Center (LDC), Dortmund
|
| 09:20 - 10:05 |
Stem cells in regenerative therapies |
| 09:20 - 09:35 |
T16 - Human iPSC-derived phagocytes as a cellular therapeutic to treat bacterial infections
Nico Lachmann, REBIRTH / Hannover Medical School (MHH)
|
| 09:35 - 09:50 |
T17 - HMGB1 accelerates regeneration of multiple tissues by transitioning stem cells to G(Alert)
Ana Isabel Espirito Santo, University of Oxford, UK
|
| 09:50 - 10:05 |
T18 - Metabolic targeting by mesenchymal stem cells in a mouse model of diet-induced NASH
Bruno Christ, University Hospital Leipzig
|
| 10:05 - 10:50 |
Stem cells in disease modeling and drug development
|
| 10:05 - 10:20 |
T19/P055A - Genetically encoded calcium indicators for drug screening in human engineered heart tissues
Umber Saleem, University Medical Center Hamburg-Eppendorf (UKE)
|
| 10:20 - 10:35 |
T20/P065 - Establishment of murine 3D bronchoalveolar lung organoids from adult somatic stem cells for organ development and disease modeling
Ana Ivonne Vazquez Armendariz, Universities Giessen & Marburg Lung Center (UGMLC)
|
| 10:35 - 10:50 |
T21 - A xenotransplantation approach using human pluripotent stem cell-derived pancreatic organoids
Meike Hohwieler, University Medical Center Ulm
|
| 11:00 - 11:15 |
Scientific working group discussions III |
|
| Lecture hall 2 |
Stem cells in regenerative therapies |
|
| Lecture hall 5 |
Stem cells in disease modeling and drug development |
|
11:00 - 11:30
|
Coffee break / Industry exhibition |
| 11:30 - 13:00 |
Concurrent strategic working group session |
|
Lecture hall 2
|
Career development
Chairs: Hartmut Geiger, Insa Schröder |
|
| 11:30 - 12:15 |
S1 - Options and opportunities for scientists in science communication
Tobias Maier, Nationales Institut für Wissenschaftskommunikation gGmbH |
|
| 12:15 - 13:00 |
S2 - Tips and tools for efficient science communication in the public and private sector
Stefanie Seltmann, Pfizer Deutschland GmbH, Berlin |
|
| Lecture hall 3 |
Technologies in stem cell research
Chairs: Andreas Bosio, Michael Cross
|
| 11:30 - 12:10 |
S3 - Reconstructing human neurogenesis using single-cell transcriptomics
Barbara Treutlein, Max Planck Institute for Evolutionary Anthropology, Leipzig |
|
| 12:10 - 12:50 |
S4 - Multimodal single cell genomics
Sascha Sauer, Max Delbrück Center Berlin |
|
| 12:50 - 13:00 |
Panel discussion on Technologies with Barbara Treutlein & Sascha Sauer; Moderation: Andreas Bosio & Michael Cross |
|
| Lecture hall 5 |
Clinical trials and regulatory affairs
Chairs: Zoltan Ivics, Ralf Sanzenbacher,Torsten Tonn |
| 11:30 - 12:00 |
S6 - Development of (stem) cell-based medicinal products: Regulatory aspects
Ralf Sanzenbacher, Paul Ehrlich Institute, Langen |
|
| 12:00 - 12:30 |
S7 - Development of (stem) cell-based medicinal products: turning research into GMP
Martin Hildebrandt, TUMCells Interdisciplinary Center for Cellular Therapies, TUM Muinch |
|
| 12:30 - 13:00 |
S8 - Development of (stem) cell-based medicinal products: Clinical Considerations for Cell-Based Therapies
Mohamed Abou-El-Enein, Berlin-Brandenburg Center for Regenerative Therapies (BCRT) |
|
13:00 – 14:30
|
Lunch break / Industry exhibition / Poster viewing
|
| 13:15 - 14:15 |
Meet-the-expert tables (limited to 10 registered participants each) |
Room 121
Room 122
Room 131
|
Ralf Sanzenbacher, PEI, Langen (ATMPs and GMP)
Andreas Bosio, Miltenyi, Bergisch Gladbach (Technologies and private sector)
Bert Klebl, LDC, Dortmund (Disease modeling and translation)
|
|
| Lecture hall 2 |
Joined session with FLI
Chair: Claudia Waskow
|
14:30 - 15:15
|
Keynote lecture
K3 - Deconstructing pancreatic development and disease with human pluripotent stem cells
Maike Sander, University of San Diego, California, USA
Chair: Julia v. Maltzahn
|
| 15:15 - 15:35 |
FLI01 - Maintenance of Jak-inhibitor treated MPN depends on cold shock protein Ybx1
Florian Heidel, Universitätsklinikum Jena
|
|
15:35 - 15:55
|
P096 - Meaningful modeling of cortical development and microcephaly in rosettes and organoids derived by combined pathway inhibition
Yechiel Elkabetz, Max Planck Institute for Molecular Genetics, Berlin
|
15:55 - 16:15
|
P117 - EOMES is a context?dependent master regulator of cardiac induction in human ES cells
Boris Greber, Max Planck Institute for Molecular Biomedicine, Münster
|
| 16:15 - 16:35 |
FLI02 - Functional relevance of Klotho for maintenance and regeneration of skeletal muscle
Julia v. Maltzahn, Leibniz Institute on Aging/Fritz Lipmann Institute (FLI), Jena
|
| Lecture hall 2 |
Closing ceremony |
| 16:35 - 17:00 |
Poster award ceremony and announcement of industry quiz winners
Daniel Besser, GSCN
|
End of GSCN conference 2017
|
| |
| Announcement: |
| 18:30 – 21:00 |
GSCN Public outreach event with panelists (in German)
Moderne Zelltherapien – Stammzellen bei Alterung, Krebserkrankungen & Organoiden
Podiumsdiskussion zur aktuellen Forschung mit Wissenschaftlern und Ärzten
Volksbad
Knebelstraße 10
07743 Jena
|
|
Grundlagenforschung an Stammzellen bietet wichtige Erkenntnisse für die Entwicklung moderner Zelltherapien. Heute erhalten Sie Antworten auf Ihre Fragen:
• Wie laufen Alternsprozesse in Stammzellen ab?
• Warum nehmen Krankheiten mit steigendem Alter zu?
• Wie können Krankheitsverläufe z.B. bei Blutkrebs durch Stammzelltherapie verändert werden?
• Welche Forschungsmöglichkeiten bieten Organoide aus Stammzellen?
• Wie ist der Stand der Forschung?
• Welche Aussichten zeichnen sich für die Klinik und die Anwendung ab?
Wissenschaftler und Ärzte aus Jena, Wien, Heidelberg und Dresden stellen den aktuellen Stand der Grundlagenforschung und den möglichen klinischen Einsatz moderner Zelltherapien vor. Kurze Filme veranschaulichen ihre Arbeit. Anschließend diskutieren die Experten Einsatzmöglichkeiten von Stammzellen bei Alternsprozessen und Erkrankungen und beantworten Fragen aus dem Publikum:
Prof. Dr. Florian Heidel, Universitätsklinikum Jena & Leibniz-Institut für Alternsforschung – Fritz-Lipmann-Institut
Prof. Dr. Jürgen Knoblich, Institut für Molekulare Biotechnologie, Wien
Prof. Dr. Andreas Trumpp, Deutsche Krebsforschungszentrum, Heidelberg
Prof. Dr. Claudia Waskow, TU Dresden
Moderation: Dr. Stefanie Seltmann
|
Thursday, 14 September
As a satellite event to the conference the non-PI meeting will be held on 14 September. In the registration process Students and Postdocs have the possibility to apply to participate in the non-PI meeting until 19 June. It offers the unique opportunity to discuss not only your most recent and exciting data but, but to also cast some light on seemingly tough problems and hurdles that you are struggling with in advancing your project. Get together with PhD students and PostDocs from various stem cell labs within the GSCN to share ideas, experiences, potential troubles and unanswered questions in an informal setting. We will dig deeper into your research results, especially roadblocks and problems, to discuss them from various perspectives. If more than 22 registrations are received, the participants will be selected by the organizers and informed by 30 June 2017. Participation is free of charge, a social evening and accommodation on the 13th of September will be covered by the GSCN.
Organizers: Giulio Abagnale (Aachen), Nicolas Huber (Jena), Juliane Jung (Jena) and Magdalena Laugsch (Cologne) |
|